Catch up with our latest volumes and outcomes data
Below we share recent volumes and clinical outcomes from a sampling of areas in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: thoracic surgery, lung transplantation and two unique populations — patients with hypertrophic obstructive cardiomyopathy and patients with pericarditis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2022):
Of 103 rated participants in this STS category, Cleveland Clinic was 1 of 15 that achieved a 3-star (highest) rating.
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-established tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Young age, solid tumor, high uptake on PET and KRAS mutation signal risk, suggest need for lobectomy
Going beyond the Eckardt symptom score to evaluate dyspepsia, eating and symptom “bother”
Long-term lung allograft outcomes clinically unaffected by organ exposure, study finds
Imaging dye enables vascular assessment to promote procedural precision and safety
Management is guided by patient and tumor characteristics, institutional expertise
A call to use lung weight in assessing need for EVLP, transplant suitability
Retrospective review documents improved outcomes and sicker patients over time
Large single-center series details outcomes of several advanced interventions